Publications

5543 Results

Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R

Authors
R Lakhotia;K Dunleavy;J Abramson;B Link;B Powell;C Melani;N Lucas;S Steinberg;JW Friedberg;B Kahl;R Little;N Bartlett;A Noy;W Wilson;M Roschewski
Journal / Conference
Blood Advances Jun 30;bloodadvances.2023010223. doi: 10.1182/bloodadvances.2023010223. Online ahead of print
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID37389844
Study Number(s)
CTSU/9177

The new NCI precision medicine Trials

Authors
L Harris;CD Blanke;HP Erba;J Ford;R Gray;ML LeBlanc;S Hu-Lieskovan;M Litzow;S Luger;F Meric-Bernstam;P O'Dwyer;M Othus;K Politi;L Shephard;C Allegra;H Chen;SP Ivy;L Korde;R Little;L McShane;J Moscow;D Patton;M Thurin;L Yee;J Doroshow
Journal / Conference
Clin Cancer Res Aug 2;CCR-23-0917. doi: 10.1158/1078-0432.CCR-23-0917. Online ahead of print, 2023
Year
2023
Research Committee(s)
Leukemia
PMID
PMID: 37531248
PMC
PMC10690084

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis

Authors
S Zarnegar-Lumley;T Alonzo;R Gerbing;M Othus;Z Sun;R Ries;J Wang;A Leonti;M Kutny;F Ostronoff;J Radich;F Appelbaum;E Pogosova-Agadjanyan;K O'Dwyer;M Tallman;M Litzow;E Atallah;T Cooper;R Aplenc;O Abdel-Wahab;A Gamis;S Luger;H Erba;R Levine;E Kolb;D Stirewalt;S Meshinchi;K Tarlock
Journal / Conference
Blood Adv. Oct 10;7(19):5941-5953
Year
2023
Research Committee(s)
Leukemia
PMID
PMID37267439
PMC
PMC10562769
Study Number(s)
S0106

Lobectomy, segmentectomy or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post-hoc analysis of CALGB 140503 (Alliance)

Authors
N Altorki;X Wang;B Damman;J Mentlick;R Landreneau;D Wigle;D Jones;M Conti;A Ashrafi;M Liberman;M de Perrot;J Mitchell;R Keenan;T Bauer;D Miller;T Stinchcombe
Journal / Conference
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Jul 18:S0022-5223(23)00612-8
Year
2023
Research Committee(s)
Lung
PMID
PMID37473998
PMC
In Process at NIHMS NIHMS1919951

The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium

Authors
A Rodday;S Parsons;J Upshaw;JW Friedberg;A Gallamini;E Hawkes;D Hodgson;P Johnson;B Link;E Mou;K Savage;P Zinzani;M Mauer;A Evens
Journal / Conference
J Clin Oncol. Apr 10;41(11):2076-2086
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID36495588
PMC
PMC10082254
Study Number(s)
S0816

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

Authors
A VanderWalde;S Bellasea;K Kendra;N Khushalani;K Campbell;P Scumpia;L Kuklinski;F Collichio;J Sosman;A Ikeguchi;A Victor;T Truong;B Chmielowski;D Portnoy;Y Chen;K Margolin;C Bane;C Dasanu;D Johnson;Z Eroglu;S Chandra;E Medini;C Gonzalez;I Baselga Carretero;A Vega-Crespo;I Perez Garciliazo;E Sharon;S Hu-Lieskovan;S Patel;K Grossmann;J Moon;M Wu;A Ribas
Journal / Conference
Nature Medicine Sep;29(9):2278-2285
Year
2023
Research Committee(s)
Melanoma
PMID
PMID37592104
PMC
PMCID10708907
Study Number(s)
S1616

The Medicaid Expansion of the Affordable Care Act and the Participation of Patients with Medicaid in Cancer Clinical Trials

Authors
J Unger;H Xiao;R Vaidya;M LeBlanc;D Hershman
Journal / Conference
JAMA Oncology Oct 1;9(10):1371-1379
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37590003
PMC
PMC10436183

Phase II Trial of Atezolizumab in BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer: SWOG S1605

Authors
P Black;C Tangen;P Singh;D McConkey;MS Lucia;W Lowrance;V Koshkin;K Stratton;T Bivalacqua;W Kassouf;S Porten;R Bangs;M Plets;IM Thompson;SP Lerner
Journal / Conference
European Urology Aug 16;S0302-2838(23)03019-1. doi: 10.1016/j.eururo.2023.08.004. Online ahead of print
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37596191
PMC
PMC10869634
Study Number(s)
S1605

Impact of race on treatment outcomes of patients with metastatic castration-sensitive prostate cancer receiving intensified androgen deprivation therapy: A post hoc analysis of the SWOG 1216 phase III trial

Authors
N Sayegh;U Swami;Y Jo;G Gebrael;B Haaland;S Gupta;M Plets;M Hussain;D Quinn;P Lara;I Thompson;N Agarwal
Journal / Conference
JAMA Netw Open Aug 1;6(8):e2326546
Year
2023
Research Committee(s)
Genitourinary
PMID
PMID37526936
PMC
PMC10394570
Study Number(s)
S1216

Assessment of Financial Screening and Navigation Capabilities at NCI Community Oncology Clinics

Authors
A Bell-Brown;K Watabayashi;D Delaney;R Carlos;S Langer;J Unger;R Vaidya;A Darke;D Hershman;S Ramsey;V Shankaran
Journal / Conference
JNCI Cancer Spectrum Aug 31;7(5):pkad055. doi: 10.1093/jncics/pkad055
Year
2023
Research Committee(s)
Cancer Care Delivery
PMID
PMID37561111
PMC
PMC10471524
Study Number(s)
S1912CD